4//SEC Filing
Brennan Daniel J. 4
Accession 0001225208-25-001969
CIK 0000885725other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:23 PM ET
Size
23.7 KB
Accession
0001225208-25-001969
Insider Transaction Report
Form 4
Brennan Daniel J.
EVP and CFO
Transactions
- Sale
Common Stock
2025-02-18$104.08/sh−2,900$301,818→ 247,248 total - Sale
Common Stock
2025-02-18$104.67/sh−14,630$1,531,366→ 232,618 total - Exercise/Conversion
Common Stock
2025-02-19$24.55/sh+18,533$454,985→ 251,151 total - Exercise/Conversion
Common Stock
2025-02-19$17.26/sh+16,865$291,090→ 268,016 total - Exercise/Conversion
Common Stock
2025-02-19$27.09/sh+15,642$423,742→ 283,658 total - Exercise/Conversion
Common Stock
2025-02-19$40.12/sh+9,483$380,458→ 293,141 total - Sale
Common Stock
2025-02-19$105.24/sh−67,333$7,086,111→ 225,808 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−15,642→ 31,285 totalExercise: $27.09Exp: 2028-02-15→ Common Stock (15,642 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−9,483→ 37,934 totalExercise: $40.12Exp: 2029-02-21→ Common Stock (9,483 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−16,865→ 0 totalExercise: $17.26Exp: 2026-02-22→ Common Stock (16,865 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-02-19−18,533→ 37,067 totalExercise: $24.55Exp: 2027-02-28→ Common Stock (18,533 underlying)
Footnotes (8)
- [F1]The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on August 26, 2024.
- [F2]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $103.35 to $104.34, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $104.37 to $105.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $105.02 to $105.46, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F5]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
- [F6]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.
- [F7]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
- [F8]Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.
Documents
Issuer
BOSTON SCIENTIFIC CORP
CIK 0000885725
Entity typeother
Related Parties
1- filerCIK 0001595612
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:23 PM ET
- Size
- 23.7 KB